Production (Stage)
Aurinia Pharmaceuticals Inc.
AUPH
$7.98
-$0.17-2.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 312.59M | 358.44M | 348.24M | 330.33M | 319.37M |
| Total Receivables | 40.55M | 37.14M | 36.48M | 25.52M | 28.91M |
| Inventory | 46.20M | 39.23M | 38.71M | 38.85M | 39.76M |
| Prepaid Expenses | 5.54M | 11.22M | 9.63M | 7.84M | 7.65M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 896.00K | 566.00K | 7.40M | 7.12M | 2.54M |
| Total Current Assets | 405.76M | 446.60M | 440.46M | 409.67M | 398.22M |
|
|
|||||
| Total Current Assets | 405.76M | 446.60M | 440.46M | 409.67M | 398.22M |
| Net Property, Plant & Equipment | 94.11M | 98.87M | 103.53M | 108.18M | 111.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.16M | 4.36M | 4.51M | 4.62M | 4.76M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 823.00K | 823.00K | 868.00K | 867.00K | 1.50M |
| Total Assets | 504.85M | 550.65M | 549.36M | 523.53M | 516.63M |
|
|
|||||
| Total Accounts Payable | 4.22M | 5.19M | 8.88M | 8.42M | 5.67M |
| Total Accrued Expenses | 41.73M | 54.12M | 46.71M | 46.92M | 41.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.54M | 15.07M | 15.95M | 14.91M | 14.72M |
| Total Finance Division Other Current Liabilities | 6.91M | 23.39M | 7.08M | 6.66M | 9.54M |
| Total Other Current Liabilities | 6.91M | 23.39M | 7.08M | 6.66M | 9.54M |
| Total Current Liabilities | 68.41M | 97.76M | 78.61M | 76.90M | 71.05M |
|
|
|||||
| Total Current Liabilities | 68.41M | 97.76M | 78.61M | 76.90M | 71.05M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 62.37M | 64.30M | 71.91M | 71.07M | 73.81M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.89M | 11.11M | 10.84M | 10.94M | 12.29M |
| Total Liabilities | 154.66M | 173.17M | 161.36M | 158.91M | 157.16M |
|
|
|||||
| Common Stock & APIC | 1.26B | 1.31B | 1.33B | 1.32B | 1.31B |
| Retained Earnings | -913.23M | -936.57M | -938.00M | -952.35M | -953.07M |
| Treasury Stock & Other | -825.00K | -647.00K | -385.00K | -859.00K | -854.00K |
| Total Common Equity | 350.19M | 377.48M | 388.00M | 364.62M | 359.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 350.19M | 377.48M | 388.00M | 364.62M | 359.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 350.19M | 377.48M | 388.00M | 364.62M | 359.48M |
|
|
|||||